BIOCOCOMER
Financiado
BIOMOLECULAR CONDENSATES AND COACERVATES FROM MEDICINE TO AGRICULTURE
BIOCOCOMER will pursue three general objectives, (Research&Innovation, Training, and International Collaboration) that will be achieved through the development of new skills and products and exchange of multidisciplinary and compl...
BIOCOCOMER will pursue three general objectives, (Research&Innovation, Training, and International Collaboration) that will be achieved through the development of new skills and products and exchange of multidisciplinary and complementary knowledge and competences within the international Partners from Italy, Australia, Portugal, Spain, Cuba, Switzerland, Germany and South Korea.
Research and Innovation Objectives:
Objective 1 Engineering and Characterising biomolecular functional condensates and coacervates
Objective 2 Understanding the behavior of the bioactive coacervates in cellular environments
Objective 3 Application of coacervates in gene editing of recalcitrant plants
Towards innovative tools for gene delivery in organisms, BIOCOCOMER is focused on the design and engineering of innovative biomolecular condensates/coacervates using peptides, proteins, polysaccharide and nucleic acids, as innovative tools for gene delivery in mammalian cells and plants. Through a combination of computer-based theoretical design and experimental and characterization approaches BIOCOCOMER is expected to generate a library of well-defined condensates and coacervates by programmed co-assembly and phase separation of mixtures of biomacromolecules, i.e polysaccharide-protein, polysaccharide-polyphenols, peptide-peptide, nucleic acid-protein. The condensates and coacervates will be engineered to readily recruit RNA and DNA molecules during phase separation in aqueous solution and to be stimuli responsive to enable transfection of mammalian cells and plants.
Scientific Impact: BIOCOCOMER will ultimately result in significant scientific breakthroughs towards innovative universal transfection tools with widespread biomedical and biotechnological applications. We intend to explore the potential of the developed platforms with the long-term aim of boosting the translational pathway of research in medicine and agriculture.
ver más
31/12/2028
Líder desconocido
1M€
Duración del proyecto: 53 meses
Fecha Inicio: 2024-07-15
Fecha Fin: 2028-12-31
Fecha Fin: 2028-12-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-07-15
Presupuesto
El presupuesto total del proyecto asciende a
1M€
Líder del proyecto
Líder desconocido